GRISACTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Grisactin, and when can generic versions of Grisactin launch?
Grisactin is a drug marketed by Wyeth Ayerst and is included in four NDAs.
The generic ingredient in GRISACTIN is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
Summary for GRISACTIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 4,531 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GRISACTIN at DailyMed |